Full Text
The Full Text of this article is available as a PDF (70.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brackmann H. H., Gormsen J. Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder. Lancet. 1977 Oct 29;2(8044):933–933. doi: 10.1016/s0140-6736(77)90871-6. [DOI] [PubMed] [Google Scholar]
- Croissant M. P., van de Pol H., Lee H. H., Allain J. P. Characterization of four monoclonal antibodies to factor VIII coagulant protein and their use in immunopurification of factor VIII. Thromb Haemost. 1986 Dec 15;56(3):271–276. [PubMed] [Google Scholar]
- Ehrenforth S., Kreuz W., Scharrer I., Linde R., Funk M., Güngör T., Krackhardt B., Kornhuber B. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet. 1992 Mar 7;339(8793):594–598. doi: 10.1016/0140-6736(92)90874-3. [DOI] [PubMed] [Google Scholar]
- Gilles J. G., Desqueper B., Lenk H., Vermylen J., Saint-Remy J. M. Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A. J Clin Invest. 1996 Mar 15;97(6):1382–1388. doi: 10.1172/JCI118558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Macik B. G. Treatment of factor VIII inhibitors: products and strategies. Semin Thromb Hemost. 1993;19(1):13–24. doi: 10.1055/s-2007-994002. [DOI] [PubMed] [Google Scholar]
- Mariani G., Ghirardini A., Bellocco R. Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee. Thromb Haemost. 1994 Jul;72(1):155–158. [PubMed] [Google Scholar]
- Nilsson I. M., Berntorp E., Freiburghaus C. Treatment of patients with factor VIII and IX inhibitors. Thromb Haemost. 1993 Jul 1;70(1):56–59. [PubMed] [Google Scholar]
- Nilsson I. M., Berntorp E., Zettervall O., Dahlbäck B. Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients. Blood. 1990 Jan 15;75(2):378–383. [PubMed] [Google Scholar]
- Schwarzinger I., Pabinger I., Korninger C., Haschke F., Kundi M., Niessner H., Lechner K. Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentrates. Am J Hematol. 1987 Mar;24(3):241–245. doi: 10.1002/ajh.2830240303. [DOI] [PubMed] [Google Scholar]
- Strauss H. S. Acquired circulating anticoagulants in hemophilia A. N Engl J Med. 1969 Oct 16;281(16):866–873. doi: 10.1056/NEJM196910162811603. [DOI] [PubMed] [Google Scholar]
- Sultan Y., Kazatchkine M. D., Maisonneuve P., Nydegger U. E. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet. 1984 Oct 6;2(8406):765–768. doi: 10.1016/s0140-6736(84)90701-3. [DOI] [PubMed] [Google Scholar]
- Sultan Y., Rossi F., Kazatchkine M. D. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies. Proc Natl Acad Sci U S A. 1987 Feb;84(3):828–831. doi: 10.1073/pnas.84.3.828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tiarks C. Y., Humphreys R. E., Pechet L. Factor VIII epitopes recognized with inhibitory monoclonal antibodies. Acta Haematol. 1990;83(2):69–75. doi: 10.1159/000205171. [DOI] [PubMed] [Google Scholar]
- Tiarks C., Ghalili K., Humphreys R. E., Goodall A. H., Tuddenham E. G., Pechet L. Identification of six functional clotting factor VIII:C epitopes by analysis of cross-reactive public idiotypes in murine monoclonal VIII:C inhibitors. Thromb Res. 1987 Mar 1;45(5):527–537. doi: 10.1016/0049-3848(87)90315-x. [DOI] [PubMed] [Google Scholar]